MENU
+Compare
IVBXF
Stock ticker: OTC
AS OF
Sep 25 closing price
Price
$12.13
Change
-$0.15 (-1.22%)
Capitalization
20.9B

IVBXF Innovent Biologics Inc. Forecast, Technical & Fundamental Analysis

Innovent Biologics, or Innovent, is one of the leading biotechnology companies in China... Show more

IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IVBXF with price predictions
Sep 25, 2025

IVBXF in downward trend: price dove below 50-day moving average on September 23, 2025

IVBXF moved below its 50-day moving average on September 23, 2025 date and that indicates a change from an upward trend to a downward trend. In of 24 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IVBXF as a result. In of 70 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IVBXF turned negative on September 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IVBXF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IVBXF broke above its upper Bollinger Band on September 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IVBXF advanced for three days, in of 47 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 211 cases where IVBXF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IVBXF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.235) is normal, around the industry mean (19.714). P/E Ratio (128.825) is within average values for comparable stocks, (54.201). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.145). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (12.563) is also within normal values, averaging (346.197).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
168 Dongping Street
Phone
+86 51269566088
Employees
5294
Web
https://www.innoventbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FOVL73.39N/A
N/A
iShares Focused Value Factor ETF
PBJL29.26-0.02
-0.09%
PGIM S&P 500 Buffer 20 ETF - Jul
IVE203.91-0.77
-0.38%
iShares S&P 500 Value ETF
TOLZ53.36-0.27
-0.50%
ProShares DJ Brookfield Global Infras
HNDL22.10-0.11
-0.51%
Strategy Shares Nasdaq 7 Handl™ ETF

IVBXF and Stocks

Correlation & Price change

A.I.dvisor tells us that IVBXF and WXXWY have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVBXF and WXXWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVBXF
1D Price
Change %
IVBXF100%
-1.26%
WXXWY - IVBXF
22%
Poorly correlated
+1.92%
ONC - IVBXF
22%
Poorly correlated
-0.34%
MDWD - IVBXF
20%
Poorly correlated
-1.78%
IVEVF - IVBXF
15%
Poorly correlated
N/A
INTI - IVBXF
11%
Poorly correlated
+13.63%
More